High Q Technologies is a fast-growing startup that focuses on developing quantum-enabled scientific instruments for ultra-high sensitivity biophysical and chemical analysis. The company's mission is to redefine the standard in protein structure determination, the future of drug discovery, and the development of novel therapeutics. High Q's patented technologies are derived from advances in experimental quantum computing, utilizing inventions created in collaboration with the University of Waterloo. It was founded in 2013 and is headquartered in Waterloo, ON, Canada. High Q Technologies recently secured a $3.75 million grant investment from FedDev on 26th February 2024. The company is backed by Quantum Valley Investments and Blackberry co-founders Mike Lazaridis and Doug Fregin. Their focus on applying modern microwave quantum optics techniques to electron paramagnetic resonance (EPR) spectroscopy paves the way for impactful innovations in the field of biophysical and chemical analysis, making High Q an exciting prospect for investors looking into cutting-edge developments in the Information Technology sector.
No recent news or press coverage available for High Q Technologies .